Intellia Therapeutics, Inc. (NTLA)

12.04 +0.42 (+3.61%) USD  |  NASDAQ  |  Feb 13, 12:53
More

Intellia Therapeutics EPS Diluted (5 Year Growth)

EPS Diluted (5 Year Growth) Chart

View EPS Diluted (5 Year Growth) for NTLA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (5 Year Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (5 Year Growth) Range, Past 5 Years

View EPS Diluted (5 Year Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (5 Year Growth) Benchmarks

View EPS Diluted (5 Year Growth) Benchmarks
Start Trial
Beam Therapeutics, Inc. Upgrade
Regeneron Pharmaceuticals, Inc. Upgrade
Pacific Biosciences of California, Inc. Upgrade
Personalis, Inc. Upgrade
Twist Bioscience Corp. Upgrade